ORG 201745
Latest Information Update: 22 Jan 2010
At a glance
- Originator Organon
- Developer Schering-Plough
- Class Contraceptives; Progesterone congeners
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Female genital diseases; Pregnancy
Most Recent Events
- 19 Nov 2007 Organon has been acquired and merged into Schering-Plough